Check-Cap Ltd. (NASDAQ: CHEK) Stock Information | RedChip

Check-Cap Ltd. (NASDAQ: CHEK)


$0.6170
+0.0270 ( +10.18% ) 32.1K

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

Market Data


Open


$0.6170

Previous close


$0.5900

Volume


32.1K

Market cap


$3.45M

Day range


$0.5600 - $0.6050

52 week range


$0.5600 - $3.4500

SEC Filings


Form Type Description Pages Date
6-k Form 6-K 1 Dec 03, 2024
6-k Form 6-K 1 Sep 13, 2024
6-k Form 6-K 1 Aug 05, 2024
20-f Annual reports 110 May 15, 2024
nt Quarterly Reports 1 May 01, 2024
6-k Form 6-K 1 Apr 29, 2024
6-k Form 6-K 3 Apr 15, 2024
6-k/a Form 6-K 4 Apr 10, 2024
6-k Form 6-K 2 Apr 08, 2024
6-k Form 6-K 4 Apr 05, 2024

Latest News